We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 1000kgs
Contract Manufacturing: CMO
Packaging Information: 25kg/drum or 1kg/bag
Delivery Lead Time: 3~5days
Sample Provided: yes
Payment Terms: T/T
Product Information:
Brand Name
Xi'an XiaoCao Botanical Development Co.,Ltd
Product Name
Hyaluronic acid
CAS #
9004-61-9
Molecular Formula
(C14H21NO11) n
PH
6.0-7.5
Content
99%
QC
ISO9001:2008 GMP Production Line
Appearance
White powder
Odour
Characteristic
Particle size
100% pass 80 mesh
Shelf Life
Two years
Main Function:
(1). Hyaluronic acid has high purification of more than 99%, with D-glucuronic acid content being more than 45%.
(2). Since Hyaluronic acid is fine classified in terms of different molecular weight , it can be tailored for customers with various requirememts.
(3). Protein content in Hyaluronic acid is very low thus hypersensitivity is prevented when using cosmetics made from Hyaluronic acid.
(4). Hyaluronic acid doesn't contain antiseptic and thickening agent. Hazardous chemicals aren't allowed to be used during production so as to guarantee HA product quality.
Packaging:1kg/bag or 25kg/drumat customer’s requirements.
Storage:Store in a cool, dry place and keep away from direct strong light.
Five years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
